Dare Bioscience
advancing products women want late stage programs cream dare | Dare Bioscience
Company
Deck Type
Sector
Industry
Deck date
February 2023
Slide
10 of 54
Similar slides by Dare Bioscience
See diffirences between slides (animation)
Investor Presentation
October 2022
advancing products women want late stage programs | Dare Bioscience
Related slides by other companies
Neumora Therapeutics
IPO
September 2023
pivotal studies designed to evaluate potential benefits of in | Neumora Therapeutics
AstraZeneca
Investor Event
December 2022
| AstraZeneca
MindMed
Investor Presentation
June 2023
phase study results key phase study results support progression of results from phase progression of clinical trial demonstrate tolerability and support linear maintained across the tested doses and clinical effects align with potent regimen suitable regimen in withdrawal aligns with preclinical evidence offers potential to be a more frequencies engagement | MindMed
ATAI
Investor Presentation
January 2024
randomized phase dose study in healthy volunteers followed by phase a open label study in | ATAI
Other recent decks by Dare Bioscience
See all presentations (5 decks)
Results
November 2023
Investor Presentation
August 2023
Investor Presentation
July 2023
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights